Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
about
Systemic Sclerosis and the Gastrointestinal Tract-Clinical ApproachMetabolic fingerprints of human primary endothelial and fibroblast cellsCytokines in the immunopathology of systemic sclerosis.Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease.Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis.
P2860
Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
@en
Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
@nl
type
label
Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
@en
Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
@nl
prefLabel
Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
@en
Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
@nl
P2860
P356
P1476
Fibroblast abnormalities in the pathogenesis of systemic sclerosis
@en
P2093
Alicia Usategui
José L Pablos
P2860
P304
P356
10.1586/ECI.11.39
P577
2011-07-01T00:00:00Z